Efficacy of Massage for the Treatment of Cancer-Related Fatigue (CRF) in Prostate Cancer Survivors (mProstate)
Cancer-related fatigue (CRF) is a prevalent and debilitating symptom experienced by cancer survivors. CRF can persist for months or years after cancer therapy is completed and has a negative impact on all areas of mental and physical function. Treatment options for CRF are extremely limited and finding safe, inexpensive, and effective interventions for managing this distressing symptom are urgently needed. Massage therapy is one of the fastest growing complementary therapies. A recently completed study in breast cancer survivors with CRF found that Swedish Massage Therapy (SMT) caused a significant reduction in fatigue and improvement in quality of life. This study investigates the effects of massage therapy on CRF among prostate cancer survivors. The study will evaluate whether SMT improves quality of life, depression, and anxiety. Second, this study will evaluate if SMT reduces CRF by decreasing the pro-inflammatory cytokine Interleukin-6 (IL-6). Lastly, to establish measures of reduced fatigue beyond self report at the treatment visits, the researchers will implement continuous, real-time monitoring of physiologic and psychological signs and symptoms, throughout the treatment period. This study will improve care for CRF and other hard-to-manage symptoms of cancer treatment and provide preliminary evidence of immune modulation as a potential mechanism of action.
This study is a randomized clinical trial to test the efficacy of Swedish massage therapy (SMT) versus an active control condition (light touch, LT) on cancer related fatigue in men with prostatic cancer, at least 2 months after the end of their radiation therapy. The primary outcome is the Multidimensional Fatigue Inventory (MFI). Secondary outcomes are the Patient-Reported Outcomes Measurement System (PROMIS) Fatigue Scale, plasma concentrations of cytokine IL-6, self-reported quality of life, depression, and anxiety, wearable measures of activity and sleep, and Automated Monitoring of Symptom Severity (AMoSS) ratings.
研究概览
详细说明
Fatigue is the most common, and one of the most devastating symptoms among patients with cancer. According to the National Comprehensive Cancer Network (NCCN), cancer-related fatigue (CRF) is "a distressing, persistent, subjective sense of physical, emotional, and/or cognitive exhaustion related to cancer or its treatment that is not proportional to recent activity". Fatigue occurs across the spectrum of cancer types and treatments. CRF has a negative impact on all areas of function, including mood, physical function, work performance, social interaction, family care, cognitive performance, schoolwork, and community activities. CRF has been rated as more troublesome and to have a greater negative impact on quality of life than other cancer-related symptoms such as pain, depression, and nausea. CRF can persist for months or years after cancer therapy is completed.
Meaningful, evidence-based treatment options for CRF are limited. Over 50% of patients with cancer have used a complementary and alternative medicine (CAM) approach for symptom management and quality of life. One of the widely employed CAM interventions is massage therapy. Most of the studies investigating massage for patients with cancer focus on depression, anxiety, or pain as the outcomes of interest. A previous investigation of breast cancer survivors reported decreases in mood symptoms and an improvement in fatigue, however, CRF was not the primary outcome measure. This randomized clinical trial will test the efficacy of Swedish massage therapy (SMT) vs. an active control condition (light touch, LT) on cancer related fatigue in men with prostatic cancer, at least 2 months after the end of their radiation therapy. Participants will receive weekly treatments for 6 weeks.
The aims of the study are as follows:
Aim 1: To conduct a feasibility study to determine whether a 6-week SMT intervention can decrease CRF among prostate cancer survivors who have received radiation therapy and have CRF.
Aim 2: To determine whether the hypothesized decrease in CRF is due to SMT modulating the immune system of subjects with CRF. The researchers hypothesize that SMT will decrease plasma concentrations of IL-6 (a pro-inflammatory cytokine) more than LT and that the decrease in plasma IL-6 will mediate the decrease in fatigue as assessed with the MFI.
Aim 3: To determine whether SMT improves self-reported quality of life, depression, and anxiety more than LT, as assessed (respectively) by the Quality of Life, Enjoyment, and Satisfaction Questionnaire - short form (Q-LES-Q), the Quick Inventory of Depressive Symptoms - Self-Report (QIDS-SR), and the Generalized Anxiety Disorder 7-item (GAD-7) scale.
Aim 4: To evaluate the peripheral physiological changes associated with treatment of CRF. The researchers predict that treatment with SMT will cause a progressive increase in wearable measures of activity and step count, improved sleep quality (duration and latency), and decrease in pulse over 6 weeks when compared to baseline measures.
Aim 5: To determine if valid and useful tests of SMT effectiveness for treating CRF can be obtained through daily self-report ratings of fatigue and continuous monitoring of physiological signs. The researchers predict that SMT will cause a significant decrease in daily self-ratings of fatigue and mood when compared to baseline ratings and that the decreases in daily self-ratings of fatigue and mood observed with SMT will correlate with changes in Q-LES-Q, QIDS-SR, GAD-7 scores obtained at in-person visits as well as physiological signs.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Georgia
-
Atlanta、Georgia、美国、30329
- Executive Park 12
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Diagnosis of prostate cancer
- At least 2 months after the end of radiation therapy
- Brief Fatigue Inventory (BFI) score of >25
- Satisfactory results of screening safety labs, serum testosterone test and drug test
- Ability to understand study procedures and to comply with them for the entire length of the study
Exclusion Criteria:
- Inability to lay supine for one hour at a time, given the nature of the massage intervention
- Actively suicidal or homicidal
- Medical conditions felt to be clinically contributing to fatigue based on the investigator's history, physical examination, and assessment: anemia (hemoglobin less than 10 g/dl), hypothyroidism (thyroid stimulating hormone greater than 4.6 microUnits per milliliter (mcU/mL)), uncontrolled pain, or medical problems associated with fatigue, including: chronic obstructive pulmonary disease, congestive heart failure, renal disease, hepatic dysfunction, autoimmune disease, neurological disorders such as multiple sclerosis or Parkinson's disease, and poorly controlled sleep apnea
- Medications felt to be clinically contributing to fatigue based on the investigator's history, physical examination, and assessment. Those may include: antidepressants, chronic use of long-acting anxiolytics or neuroleptics
- Treatment with high dose systemic corticosteroids or continuous use of other immunosuppressants within the past 30 days
- Unable to comply with the protocol for any reason
- Use of non-steroidal anti-inflammatory drugs; aspirin use is allowed but must be tracked
- Illicit drug use
- Shift work
- Currently dieting
- Excessive, regular use of alcohol (more than two 5 ounce glasses of wine or equivalents/day) or a history of binge drinking (more than 7 drinks/24 hour period) within the last 6 months
- Have used massage as a therapeutic modality (medical or psychological) at any point for the treatment of medical conditions
- Have massages on a regular basis, defined as receiving 4 or more massages per year for the last 5 years
- Currently employing any other complementary and alternative medicine (CAM) manual therapy and/or holistic therapies to treat a perceived health problem
- Unable to read and understand the informed consent document because of language difficulties
- Inability or unwillingness to give written informed consent
学习计划
研究是如何设计的？
设计细节
- 主要用途：支持治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Swedish Massage Therapy
Participants in this arm will receive Swedish massage, which is the most commonly offered and best-known type of massage.
|
The therapist uses non-aromatic massage oil to facilitate making long, smooth strokes over the body.
Swedish massage is done with the subject covered by a sheet, a technique called "draping."
One part of the body is uncovered, massaged, and then covered up before moving onto another part of the body.
Primary techniques used in the research protocol therapy are: effleurage, petrissage, tapotement.
These will be administered according to a very specific, standardized protocol.
The total session time will be 45 minutes.
其他名称：
|
|
有源比较器：Light Touch Intervention
Participants in this arm will receive light touch only.
|
The light-touch research intervention is based on the concept that there will be a noticeable effect with regard to massage when compared to light-touch alone without the massage.
The protocol followed will be the same as the massage protocol other than that the therapist will use light-touch only.
The total session time will be 45 minutes.
其他名称：
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Multidimensional Fatigue Inventory (MFI) score
大体时间：Baseline, Week 6
|
Multidimensional Fatigue Inventory (MFI) is a brief (20-item) self-report instrument that assesses 5 dimensions (subscales) of fatigue, including general fatigue, physical fatigue, mental fatigue, reduced activity, and reduced motivation.
Respondents indicate their level of agreement with fatigue related statements on a 5 point scale ranging from "Yes, that is true" = 1 to "No that is not true" = 5.
Possible scores for each subscale range from 4 (no fatigue) to 20 (maximum fatigue).
The primary outcome measure for this study will be the total of four MFI subscales (general fatigue, physical fatigue, reduced activity, and reduced motivation).
|
Baseline, Week 6
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Patient-Reported Outcome Measurement System (PROMIS) Fatigue Scale score
大体时间：Baseline, Week 6
|
The PROMIS Fatigue Scale is an 7-item self-report scale.
Respondents indicate how tired they feel by answering fatigue related questions (such as "How often did you feel tired?") on a scale of 1 (never) to 5 (always).
The summary score ranges from 7 to 35 with higher values equating to increased levels of fatigue.
|
Baseline, Week 6
|
|
Change in plasma IL-6
大体时间：Baseline, Week 6
|
To examine the effects of SMT on the pro-inflammatory cytokine IL-6, blood will be drawn at each study visit and the plasma levels of IL-6 will be compared between prior to treatment and at treatment completion.
|
Baseline, Week 6
|
|
Change in Quality of Life, Enjoyment, and Satisfaction Questionnaire - short form (Q-LES-Q) score
大体时间：Baseline, Week 6
|
The Q-LES-Q short form is a 16-item, patient-administered instrument, which asks participants to rate their satisfaction with 13 specific areas of life, specifically, overall sense of well-being, medication, and overall life satisfaction and contentment during the past week.
Responses are given on a 5-point scale where 1 = very poor and 5 = very good.
Items 1-14 are added in order to obtain a summary score while the last two items are stand alone questions.
Total scores range from 14 to 70 and higher scores indicate greater satisfaction with life.
|
Baseline, Week 6
|
|
Change in Quick Inventory of Depressive Symptomatology - Self-Report (QIDS-SR) score
大体时间：Baseline, Week 6
|
The QIDS-SR is a 16-item questionnaire covering nine diagnostic symptom domains that characterize a major depressive episode (sleep disturbance, sad mood, changes in appetite/weight, concentration, self-criticism, suicidal ideation, interest, energy/fatigue, and psychomotor agitation/retardation).
The total score can range from 0 -27.
A score of 1-5 equate to no depression while a score of 21-27 indicates very severe depression.
|
Baseline, Week 6
|
|
Change in Generalized Anxiety Disorder 7-item (GAD-7) Scale score
大体时间：Baseline, Week 6
|
The GAD-7 is a 7-item, well-validated patient self-report scale of anxiety.
Participants respond to statements to indicate how often they have been bothered by specified symptoms of anxiety (such as "feeling nervous, anxious, or on edge).
Response choices include 0 = not at all sure, 1 = several days, 2 = over half the days, and 3 = nearly every day.
Total scores range from 0 to 21 with higher scores indicating increased anxiety.
|
Baseline, Week 6
|
|
Change in circadian variation of activity
大体时间：Baseline, Week 6
|
Activity level will be assessed by examining circadian variation (daily biologic cycles) of activity.
Daily activity of each participant will be measured with a multisensor wristband device (Jawbone UP3).
The device will collect data on activity levels and sleep metrics as participants wear the device throughout the study.
|
Baseline, Week 6
|
|
Change in step count
大体时间：Baseline, Week 6
|
The number of steps the participant takes each day will be measured with a multisensor wristband device (Jawbone UP3).
The device will collect data on activity levels and sleep metrics as participants wear the device throughout the study.
|
Baseline, Week 6
|
|
Change in sleep duration
大体时间：Baseline, Week 6
|
The number of hours the participant sleeps each night will be measured with a multisensor wristband device (Jawbone UP3).
The device will collect data on activity levels and sleep metrics as participants wear the device throughout the study.
|
Baseline, Week 6
|
|
Change in sleep latency
大体时间：Baseline, Week 6
|
The amount of time it takes for the participant to fall asleep will be measured with a multisensor wristband device (Jawbone UP3).
The device will collect data on activity levels and sleep metrics as participants wear the device throughout the study.
|
Baseline, Week 6
|
|
Change in Automated Monitoring of Symptom Severity (AMoSS) survey score
大体时间：Baseline, Week 6
|
AMoSS is a smartphone app designed for longitudinal evaluation of mood states and sociability.
Using this type of technology may help to better understand the day-to-day impact of SMT on the lives of cancer survivors with CRF, by means of a short pop-up survey that assesses sadness, anxiety, fatigue, irritability, and energy.
Mood/fatigue will be assessed daily with reminders provided by the app via an alert.
|
Baseline, Week 6
|
合作者和调查者
调查人员
- 首席研究员：Mark Rapaport, MD、Emory University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- IRB00095260
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.
Swedish Massage Therapy的临床试验
-
University of Applied Sciences and Arts of Southern...Vrije Universiteit Brussel; Universiteit Antwerpen; THIM - die internationale Hochschule für Physiotherapie完全的
-
Abbott Medical Devices完全的